Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Rare symbols : Pfe save search
Global Rare Hemophilia Factors Market Analysis Report 2023-2030 - Tailored Factor Concentrates Gain FDA Approval, Fueling Rare Hemophilia Factors Market Growth
Published: 2023-10-03 (Crawled : 01:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.29%
H: 0.8%
C: 0.18%
fda rare report global growth market
Voyager Therapeutics Announces Pfizer License of Next-Generation AAV Capsid for Rare Neurologic Disease Target
Published: 2022-10-04 (Crawled : 11:00) - ir.voyagertherapeutics.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.25%
H: 1.33%
C: 0.47%
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: 6.57%
H: 13.17%
C: 10.17%
rare disease license therapeutics
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
Published: 2022-08-08 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.24%
H: 0.85%
C: 0.36%
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.73%
H: 0.53%
C: -0.84%
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 41.47%
H: 0.0%
C: 0.0%
blood rare global acquire therapeutics
Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress
Published: 2022-05-12 (Crawled : 14:20) - prnewswire.com
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -0.2%
H: 1.54%
C: 0.57%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
rare asco cancer
Pfizer and Beam Enter Exclusive Multi-Target Research Collaboration to Advance Novel In Vivo Base Editing Programs for a Range of Rare Diseases
Published: 2022-01-10 (Crawled : 12:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.63%
H: 0.0%
C: 0.0%
BEAM | $23.9 -1.69% -1.72% 4.5M
|
Health Technology
|
| O: 3.65%
H: 0.77%
C: -2.89%
disease rare
Global Rare Hemophilia Factors Market Research Report 2021: Market to Surpass $350 Million by 2027 - Fresh Frozen Plasma to Account for 168.1 Million of the Total Market
Published: 2021-07-21 (Crawled : 21:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.24%
H: 1.05%
C: 0.85%
research market rare
Collaboration Between AbbVie, Biogen and Pfizer Creates World’s Largest Browsable Resource Linking Rare Protein-Coding Genetic Variants to Human Health and Disease
Published: 2021-07-08 (Crawled : 23:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.71%
H: 1.44%
C: 0.2%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.04%
H: 0.88%
C: 0.24%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
disease genetic collaboration rare
A Growing Market For Rare Disease Treatments Opens Up New Opportunities
Published: 2021-04-28 (Crawled : 13:00) - prnewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.23%
H: 1.04%
C: 0.7%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.2%
H: 0.21%
C: -0.54%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.21%
H: 0.43%
C: -0.11%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -5.33%
H: 1.01%
C: -1.99%
disease treatment growing rare
Dewpoint Announces Collaboration with Pfizer to Develop Potential Therapies for a Rare Form of Muscular Dystrophy
Published: 2021-01-06 (Crawled : 14:00) - biospace.com/
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.97%
H: 1.76%
C: 0.11%
collaboration announces collaboration therapy potential rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.